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Abstract
Background: Despite international data indicating that Enhanced Recovery After Surgery (ERAS) programs, which
combine evidence-based perioperative strategies, expedite recovery after surgery, few centers have successfully
adopted this approach within the U.S. We describe the implementation and efficacy of an ERAS program for
colorectal abdominal surgery in a tertiary teaching center in the U.S.
Methods: We used a multi-modal and continuously evolving approach to implement an ERAS program among
all patients undergoing colorectal abdominal surgery at a single hospital at the University of California, San
Francisco. 279 patients who participated in the Enhanced Recovery after Surgery program were compared to
245 previous patients who underwent surgery prior to implementation of the program. Primary end points
were length of stay and readmission rates. Secondary end points included postoperative pain scores, opioid
consumption, postoperative nausea and vomiting, length of urinary catheterization, and time to first solid
meal.
Results: ERAS decreased both median total hospital length of stay (6.4 to 4.4 days) and post-procedure length
of stay (6.0 to 4.1 days). 30-day all-cause readmission rates decreased from 21 to 9.4 %. Pain scores improved
on postoperative day 0 (3.2 to 2.1) and day 1 (3.2 to 2.6) despite decreased opioid. Median time to first solid
meal decreased from 4.7 to 2.7 days and duration of urinary catheterization decreased from 74 to 46 h. Similar
improvements were observed in all other secondary end points.
Conclusions: These results confirm that a multidisciplinary, iterative, team-based approach is associated with a
reduction in hospital stay and an acceleration in recovery without increasing readmission rates.
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Background
Significant improvements in recovery after major
abdominal surgery can be achieved by implementing a
standardized protocol of evidence-based treatments over
the entire perioperative period [1–4]. First proposed by
Kehlet et al. in 1994 [5, 6], this approach has coalesced
into Enhanced Recovery After Surgery (ERAS) protocols
which have evolved into a broader concept termed the
Perioperative Surgical Home [7]. The underlying goals of
this approach are to decrease variability in practice,
reduce morbidity, enhance rate of recovery, and shorten
postoperative length of stay (LOS).
Results from previously published reports [8–12] and
systematic reviews [13–16] have been encouraging, with
wide adoption in Europe [10]. However, in countries where
healthcare management and resources are decentralized,
ERAS programs can face substantial challenges for imple-
mentation. While there is a consistent body of literature
validating the benefit of perioperative optimization, there
are limited studies reporting successful implementation
from the United States [17, 18].
We present a multi-disciplinary and iterative approach to
implementing an ERAS protocol among patients undergo-
ing abdominal colorectal surgery at University of California,
San Francisco. During implementation, we monitored
compliance on a monthly basis which directed us to areas
for continuous process improvement in the protocol and
led to targeted educational efforts for patients, faculty and
staff. To evaluate the effectiveness of this program, we
analyzed data on hospital LOS, readmission rates, pain
management, and bowel and bladder function among 279
patients undergoing surgery after implementation of the
ERAS program, and compared that with 245 consecutive
patients who had undergone surgery immediately prior to
implementation.
Methods
The Institutional Review Board at the University of
California – San Francisco (UCSF) approved the study
in September 2013 (Study Number 13-11613). The study
was conducted at one of the tertiary care teaching hos-
pital sites of UCSF- Mount Zion Hospital. Four board-
certified colorectal surgeons performed all surgeries.
Multi-disciplinary team
We sought institutional commitment to develop an
Enhanced Recovery After Surgery Program (ERAS) as a
quality initiative and were given support of two
personnel from the quality and safety program to assist
with obtaining information on current quality and
patient satisfaction. We were also given information
technology support to develop a program for extracting
data from our electronic medical record system. In July
2013, we created a multidisciplinary committee, ERAS
Working Group, comprising of participants from
Colorectal surgery, Anesthesiology, Pain management,
Nursing, and Nutritional Services.
ERAS phase
After reviewing published literature on successful
ERAS programs, primarily from Europe, and following
discussions with several national and international
experts on ERAS, the Working Group developed a
program for the perioperative management of patients
having abdominal colorectal surgery at UCSF-Mt.
Zion campus (See Additional file 1 - UCSF ERAS
Protocol). The program provided a standardized path-
way that guided the perioperative management of
patients undergoing major abdominal colorectal sur-
gery at UCSF-Mt. Zion. However, individual health
care providers were allowed to deviate from the
pathway if necessary. Preoperatively, patients were ed-
ucated on the ERAS program and provided with writ-
ten instructions and an informational pamphlet that
also contained a brief exercise program with a focus
on improving stability and mobility (See Additional
file 2 - UCSF ERAS Patient Instructions). Patients
were allowed to drink clear liquids until 4 h prior to
the time of the procedure. Bowel preparation instruc-
tions did not change before and after the ERAS
program. In general, surgeons avoided mechanical
bowel preparation for right sided resections but gave
a full bowel preparation for left sided and rectal
lesions. Preoperatively, patients were given oral pre-
emptive non-opioid analgesics, anti-emetic medica-
tions, deep vein thrombosis (DVT) prophylaxis and
intravenous antibiotics. During surgery, guidelines for
the conduct of anesthesia were provided, including
restriction of intravenous fluids to approximately 2 l per
routine case, use of epidural analgesia, minimizing opioid
administration and providing adequate antiemetic prophy-
laxis. Postoperatively, the pathway provides specific
instructions for non-opioid pain control, ambulation,
DVT prophylaxis, and oral intake.
Iterative evolution
Every month the ERAS Work Group met to discuss the
implementation of the program. The group devised
methods for capturing relevant data, analyzed the
collected data, monitored protocol compliance and initi-
ated changes to improve the outcomes for the patients.
For example, we identified an area of potential low
protocol compliance and attempted to verify its validity.
Significant work was done to improve nursing reporting
and documentation of parameters such as incentive
spirometer use, ambulation and preoperative carbohy-
drate drink intake. This allowed us to improve our
overall implementation.
Sarin et al. BMC Anesthesiology  (2016) 16:55 Page 2 of 10
Study design
The program was introduced gradually in September 2013
and was fully in place by December 2013. We collected
prospective demographic, co-morbidity, and perioperative
data on consecutive patients undergoing abdominal
colorectal surgery after implementation of the program
from December 2013 to November 2014. We measured
ERAS compliance by tracking the percentage of patients
receiving epidurals and non-opioid medications, and per-
centage of patients ambulating daily.
The predetermined primary outcome measures were
total hospital LOS, post procedure LOS and 30-day re-
admission rates. Total hospital LOS was defined as time
from admission to discharge; the post-procedure LOS as
the time from completion of surgery to discharge.
Readmission was defined as any cause readmission to a
system hospital within 30 days of surgery. Secondary out-
come measures included postoperative pain scores, median
opioid consumption intraoperatively and postoperatively in
milligrams (mg) oral morphine equivalents, post-operative
nausea and vomiting (PONV) rates, duration of epidural
catheterization, duration of urinary catheterization, per-
centage of patients nil per os (NPO) on postoperative day
(POD) 0 to POD 2 and number of days to first solid meal.
Pain was assessed using the patient-reported Numerical
Rating Scale 0 to 10, on which “0” represents no pain and
“10” represents the worst possible pain.
After 1 year of data collection and protocol refinement
(December 2013 to November 2014 – ERAS Phase), the
number of patients (279) and procedures (310) were tabu-
lated. We then reviewed the number of patients who had
undergone major abdominal colorectal surgery in the
months preceding the start of ERAS implementation. In
order to achieve near-equivalent numbers of patients and
procedures, we defined a Pre-ERAS phase as the 14 months
from June 2012 to August 2013. This group was comprised
of 245 patients having 298 procedures taken consecutively
from operating room records. Retrospectively collected
data from these Pre-ERAS phase patients were then com-
pared to those patients undergoing surgery during the
ERAS phase. We chose to exclude data collected between
September and November 2013 during the rollout of the
ERAS program to allow for adoption and training.
Statistical analysis
Descriptive statistics of the pre-ERAS and ERAS groups
were compared for all relevant patient characteristics,
perioperative and postoperative data. Statistical compari-
sons between pre-ERAS and ERAS groups were
performed using t-tests, Mann–Whitney U tests, and
Fisher’s exact tests as appropriate. The statistical signifi-
cance level for all comparisons was set at a two-tailed
alpha = 0.05. All analyses were performed using R
version 3.1.2 (R Foundation for Statistical Computing,
Vienna, Austria).
Results
There were 298 procedures on 245 individual patients in
the Pre-ERAS group and 310 procedures on 279 individual
patients in the ERAS Group. Relevant patient characteris-
tics are shown in Table 1. There was no statistically signifi-
cant difference in age, body mass index, or ASA rating.
However, there were more men in the pre-ERAS group.
Chronic health conditions such as diabetes and chronic
cardiac conditions were equally represented in the two
groups but rates of smoking and hypertension were higher
in the pre-ERAS group than in the ERAS group. There
Table 1 Patient Characteristics








Individuals Patients, n 245 279
Age Median age, years (Range) 54 (20–95) 53 (17–90) 0.44
Sex Male patients, n (%) 169 (57 %) 137 (44 %) 0.0015
BMI Median BMI, kg/m2 (Range) 25.5 (14.9–52.7) 24.1 (14.8–49.3)
American Society of Anesthesiologists’
(ASA) classification
ASA Grade 1, n (%) 4 (1.3 %) 6 (1.9 %) 0.65
ASA Grade 2, n (%) 199 (66.8 %) 208 (67.1 %)
ASA Grade 3, n (%) 90 (30.2 %) 95 (30.6 %)
ASA Grade 4, n (%) 5 (1.7 %) 1 (0.3 %)
Smoker Smokers, n (%) 24 (8.1 %) 9 (2.9 %) 0.0065
Diabetes Diabetes, n (%) 23 (7.7 %) 21 (6.8 %) 0.75
Hypertension Hypertension, n (%) 41 (14 %) 22 (7.1 %) 0.0077
CHD Chronic heart disease, n (%) 25 (8.4 %) 14 (4.5 %) 0.068
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were no patients or procedures excluded or deleted from
either cohort of consecutive cases enrolled in the analysis.
Relevant surgical details are shown in Table 2. There
was no significant difference in the primary indication
for surgery. Colorectal cancer, inflammatory bowel
disease, and other indications were equally represented
in the pre-ERAS and ERAS groups. The number of
patients who underwent open versus minimally invasive
(laparoscopic / robotic) surgery in the pre-ERAS and
ERAS groups was similar. The median duration of
surgery was longer in the pre-ERAS group. The blood
loss did not differ between the two groups. The distri-
bution of types of cases between the two groups is
shown in Table 3.
Program adherence measures are shown in Table 4. A
higher percentage of patients in the ERAS group received
preoperative non-opioid analgesics (acetaminophen, diclo-
fenac, gabapentin) as well as scopolamine. The percentage
of patients receiving epidurals and transversus abdominis
plane (TAP) blocks also increased significantly. The rates of
ketamine infusion and ondansetron dosing intraoperatively
did not differ significantly between the pre-ERAS and
ERAS groups but the use of intraoperative dexamethasone
was higher in the ERAS group.
As shown in Table 4, the rates of intraoperative
chemical DVT prophylaxis and IV antibiotic use prior to
the procedure also increased. We found that the median
volume of crystalloid used was lower in the pre-ERAS
than in the ERAS group. However, the median volume of
colloid used was significantly lower in the ERAS group.
Postoperatively, a significantly higher percentage of
patients in the ERAS group received scheduled non-
opioid analgesics (acetaminophen, diclofenac, gabapentin)
as well as scopolamine. Percentage of patients ambulating
on POD 0 to 2 was also significantly higher in the ERAS
group compared to the pre-ERAS group.
Table 5 shows the results of the primary outcome
measures. As shown, there was a reduction in the
median total hospital LOS (from 6.4 to 4.4 days) as well
as a reduction in post procedure LOS (from 6.0 days to
4.1). In addition, the 30-day readmission rate was signifi-
cantly lower for the ERAS group at 9.4 % compared to
21 % for the pre-ERAS group.
Outcomes of the pain management protocol are
shown in Table 6. The median opioid consumption (in
Table 2 Details of Surgery
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mg oral morphine equivalents) decreased in the ERAS
group compared to the pre-ERAS group both intraoper-
atively and postoperatively. The median duration of
epidural catheterization also decreased significantly from
95 to 52 h. Patient self-reported postoperative pain
scores were significantly improved on POD 0 and 1 but
no difference was found in the two groups on POD 2.
Effect of the program on bowel and bladder function is
shown in Table 7. PONV was measured as a combination
of antiemetic use and patient self-reported nausea or
vomiting in the immediate postoperative period. While
there was no difference in the amount of anti-emetics used
in the pre- ERAS and ERAS groups, the subjective report-
ing of nausea/vomiting by patients was significantly
reduced in the ERAS group. We used sequential dietary
orders as a surrogate for bowel function. In comparing the
pre-ERAS group to the ERAS group, the percentage of
patients who were NPO decreased from 61.7 to 29 % on
POD 0; 30.9 to 14.5 % on POD1 and 12.1 to 9.4 % on POD
2 respectively. While the difference in POD 0 and 1 was
statistically different, it was not on POD 2. The median
time to first solid meal decreased significantly from 4.7 days
in the pre-ERAS group to 2.7 days the ERAS group. The
median duration for urinary catheterization decreased from
74 h in the pre-ERAS group to 46 h in the ERAS group.








Acetaminophen n (%) 28 (9.4 %) 277 (89.4 %) <0.001
Diclofenac n (%) 2 (0.7 %) 104 (33.5 %) <0.001
Gabapentin n (%) 20 (6.7 %) 281 (90.6 %) <0.001
Scopolamine n (%) 2 (0.7 %) 68 (21.9 %) <0.001
Regional analgesia usage Epidural used for intraoperative
analgesia, n (%
78 (26.2 %) 185 (59.7 %) <0.001
Epidural used for postoperative
analgesia, n (%)
86 (29 %) 210 (68 %) <0.001
TAP block given for intraoperative
analgesia, n (%)
9 (3 %) 26 (8.4 %) 0.005
Adjunctive intraoperative
medications
Intraoperative Ketamine Infusion, n (%) 20 (6.7 %) 29 (9.4 %) 0.24
Intraoperative Dexamethasone, n (%) 90 (30.2 %) 133 (42.9 %) 0.0014
Intraoperative Ondansetron, n (%) 260 (87.2 %) 272 (87.7 %) 0.9
Chemical DVT prophylaxis Preoperative DVT prophylaxis with
subcutaneous Heparin, n (%)
100 (34 %) 273 (88 %) <0.001
Preoperative antibiotic Intravenous antibiotics given
before incision, n (%)
268 (90 %) 300 (97 %) 0.0008
Intraoperative fluids Median introperative crystalloid, ml
(min, 1st Q, 3rd Q, max)
1350 (0, 800, 2000, 30,000) 1500 (0, 862.5, 2500, 18,000) 0.027
Median intraoperative colloid, ml
(min, 1st Q, 3rd Q, max)
0 (0, 0, 500, 6000) 0 (0, 0, 0, 4500) <0.001
Post-operative non opioid
medications scheduled usage
Acetaminophen n (%) 192 (64.4 %) 289 (93.2 %) <0.001
Diclofenac n (%) 5 (1.7 %) 70 (22.6 %) <0.001
Gabapentin n (%) 23 (7.7 %) 254 (81.9 %) <0.001
Scopolamine n (%) 80 (26.8 %) 188 (60.6 %) <0.001
Adherence to ambulation Patients Ambulating on POD 0, n (%) 15 (5.0 %) 309 (99.7 %) <0.001
Patients Ambulating on POD 1, n (%) 91 (30.5 %) 307 (99.0 %) <0.001
Patients Ambulating on POD 2, n (%) 97 (32.6 %) 299 (96.5 %) <0.001








Median total hospital length
of stay from admission to
discharge, days (range)
6.4 (0.2–197.7) 4.4 (1.0–80.4) <0.001
Median post procedure length
of stay from end of procedure
to discharge, days (range)
6.0 (0.1–161.5) 4.1 (0.8–47.0) <0.001
Readmission rate 30 day all
cause readmission rate, n (%)
64 (21 %) 29 (9.4 %) <0.001
Reoperation rate reoperation
for any indication within
30 days, n (%)
5 (2 %) 6 (2.1 %) 1
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Discussion
Our development of a multidisciplinary, evidence-
based, enhanced recovery after surgery program at a
major tertiary medical center performing abdominal
colorectal surgery was associated with shortened LOS
and reduced readmission rates. We were also able to
show an improvement in pain control, and reduced
opioid consumption and postoperative nausea – all
leading to an accelerated return of bowel and bladder
function. These results are consistent with findings
from other centers and in varied patient populations
[8, 11–20] and lends impetus to the push for further
incorporation of such programs in current clinical
practice within in the U.S.
Patient education and defining expectations were
cornerstones of our program to ensure patient participa-
tion is well-established [21, 22]. Comprehensive patient
instructions including a website (http://eras.surgery.ucs
f.edu) allowed for a step-by-step overview of the pro-
gram. Patients who were informed to walk on the day of
surgery and to be home in 3–4 days were more likely to
accept this newer paradigm. The preoperative exercise
program in the patient instructions was designed in
collaboration with a physical therapist. It focused on
improving balance and core strength to facilitate stability
and mobility after the operation. Similarly, incentive
spirometer teaching occurred preoperatively, which
established baseline spirometer goals for patients to
work towards postoperatively.
There has been a major move away from prolonged
fasting to permitting clear fluids up to two hours prior
to surgery and solids up to 6 h prior to surgery in ac-
cordance with the ASA guidelines. In keeping with the
evidence [23–26], our patients were allowed clear liquids
and asked to drink a carbohydrate-rich clear liquid up to
4 h prior to surgery. Four hours was chosen as a cut off
to allow for flexibility in the event the procedure could
be done earlier than anticipated. Benefits of the nutri-
tional drink include reduced catabolism, improved post-
operative insulin sensitivity, reduced LOS and improved
patient satisfaction by reducing preoperative thirst,
hunger, and discomfort [23, 27–31].
Even though the carbohydrate drink requirement was a
part of the protocol and not optional, rates of adherence
to this component were quite variable. Our analysis of the
reasons for this variability included (1) availability of the
drink to give to patients in the clinic, (2) whether the sur-
gery was booked in the clinic vs. over the phone and (3)






Median opioid consumption Intraoperative
(mg po morphine equivalents)
Intraoperative opioid
consumption, mg (range)
99.0 (0.0–605.0) 68.0 (0.0–293.0) <0.001
Median opioid consumption from POD 0 to POD 2
(mg po morphine equivalents)
IV and PO opioid consumption,
mg (range)
142.2 (0.0–1964.0) 75.0 (0.0–3162.0) <0.001
Epidural opioid consumption,
mg (range)
299.3 (7.6–1017.1) 209.8 (7.8–788.5) <0.001
Median Duration of Epidural catheterization (in hours) Epidural duration – median,
H (range)
95 (25–264) 52 (3–261) <0.001
Median Patient self-reported pain scores from
10 (worst) to 0 (no pain).
POD 0 score, n (range) 3.2 (0.0–8.8) 2.1 (0.0–9.3) <0.001
POD 1 score, n (range) 3.2 (0.0–8.3) 2.6 (0.0–9.6) 0.0019
POD 2 score, n (range) 2.5 (0.0–10.0) 2.7 (0.0–9.1) 0.77






Need for postoperative antiemetics Received antiemetic in post
anesthesia care unit, n (%)
181 (60.7 %) 207 (66.8 %) 0.13
Patient self reported postoperative
nausea and vomiting
Postoperative nausea and vomiting
in post anesthesia care unit, n (%)
125 (41.9 %) 74 (23.9 %) <0.001
Percentage of patient ordered nothing
by mouth (NPO) post-operatively
Patients NPO on POD 0, n (%) 184 (61.7 %) 90 (29.0 %) <0.001
Patients NPO on POD 1, n (%) 92 (30.9 %) 45 (14.5 %) <0.001
Patients NPO on POD 2, n (%) 36 (12.1 %) 29 (9.4 %) 0.13
Days from admission to 1st solid meal Median time to first solid diet, days (range) 4.7 (0.6–23.7) 2.7 (0.8–37.7) <0.001
Duration of urinary catheterization with
a Foley Catheter (in hours)
Foley Duration –Median, h (range) 74 (2–649) 46 (1–2262) <0.001
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patient concerns with violating the traditional “NPO after
midnight” instruction. In addition, we were hampered by
uneven charting of NPO status and carbohydrate intake
by preoperative nursing personnel. Over time, the rates of
adherence did improve due to the focused efforts of the
Working Group to improve compliance with this element
of the pathway.
Intraoperatively, fluid restriction was an established
practice prior to the program based on studies showing
reduced complications [32, 33]. The goal was to main-
tain a fluid restrictive strategy that was statistically sig-
nificant; however, a small (150 ml) increase in crystalloid
administration was detected. Despite some recent evi-
dence suggesting that fluid restriction may not accelerate
recovery as previously thought [34, 35], we believe that
our findings reflect a trend towards use of crystalloid in
preference to colloid administration. Additionally, we
increased the compliance of perioperative DVT prophy-
laxis and antibiotic administration [36] quality, perhaps
as a result of increased attention.
Optimizing perioperative pain management while
reducing opioid use were major goals of the ERAS pro-
gram. Our pain management strategy incorporated
recent evidence and expert opinion in designing the
analgesic protocols [37] with modifications in the use of
neuraxial anesthesia, ketamine, acetaminophen, gaba-
pentin and COX-inhibitors.
We chose to use thoracic epidural analgesia (TEA)
despite recent literature [37, 38] suggesting that recovery
from laparoscopic colorectal procedures may not benefit
from TEA. However as a tertiary referral center, redo
operations, pelvic surgeries and stomas are more
commonplace than simple colectomies. The routine use
of a hand-assisted port, typically involving a 6–8 cm
infra-umbilical vertical or transverse incision and a sig-
nificant number of ‘open’ surgeries suggested important
benefit would be derived from placement of TEA. [39]
We chose to use a low concentration of ropivacaine
(0.0625 %) to mitigate risk of hypotension, motor
dysfunction, and ease the transition when the epidural is
removed on POD 2. In addition, all patients with TEA
were followed by an inpatient acute pain service that
adjusted the TEA infusion rates to optimize pain control
and prevent lower extremity motor weakness, which
would have impaired early mobilization.
Patients, who required more than 100 mg oral
morphine equivalents per day, had a sub-anesthetic dose
of ketamine infusion added in their therapy for anti-
hyperalgesia. Additional benefits included the reduction in
opioid consumption by 35–50 % [40, 41] and a decreased
development of persistent post-surgical pain [42, 43] with-
out significant adverse effects [43]. Other opioid-sparing
strategies included administration of acetaminophen and
gabapentin through all phases of care.
Adjuncts used for PONV such as dexamethasone and
scopolamine may have also contributed to post-operative
pain management and opioid reduction [44, 45]. There
were improvements in early postoperative pain scores as
well as decreased overall opioid consumption when we
followed an evidence-based multimodal pain management
strategy.
Early mobilization and diet advancement have become
a foundation of any rapid recovery protocol [46, 47]. We
instituted a similar protocol and combined these
measures with rapid de-escalation of fluids and gum
chewing, which have also been shown to hasten bowel
recovery [48, 49].
The pre-ERAS and ERAS groups are well-balanced with
no difference in age, BMI, morbidities (ASA classification),
indication for surgery as well as operative approach (open
versus minimally invasive).
We chose LOS as our primary outcome measure as a
surrogate of postoperative inpatient recovery. Rapid
recovery from surgery and therefore early discharge is
limited by pain, organ dysfunction, nausea and vomiting,
ileus, hypoxemia, fatigue and immobilization [50]. In
addition, LOS is also influenced by demand factors
(patient’s need for care influenced by age, severity of
disease and complications, co-morbidity and social cir-
cumstances [51] and supply factors including clinical
practice style, availability of beds and discharge policies
[52, 53]. The goal of building a multifocal accelerated
pathway is to influence all of these factors to some de-
gree. Therefore, LOS serves as a reasonable measure to
assess the efficacy of this type of intervention.
Total LOS and post-procedure LOS were assessed
independently. For example, patients with inflammation
or obstruction were often medically treated before surgi-
cal intervention. Readmission rates were also a primary
outcome measure. Adopting an early discharge strategy
that substituted additional days spent in the hospital
with a higher readmission rate would only shift recovery
to home rather than enhancing recovery. As noted, we
were able to show that an ERAS program reduced
readmission rates while shortening LOS.
Recovery of bowel function was assessed using immedi-
ate PONV and time to first meal. We tracked both anti-
emetic use and patient reporting of nausea. We were
unable to detect a change in the amount of anti-emetics
administered postoperatively; however, patients reported
feeling better in the immediate postoperative period. This
finding may be directly related to application of preopera-
tive scopolamine patch along with intraoperative adminis-
tration of dexamethasone and ondansetron. Reduced
opioid consumption may also be a contributing factor to
reduced nausea. We were able to show a significant
improvement in bowel recovery when measured by pro-
gressive percentage of patients NPO postoperatively and
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time to first solid meal. As expected by POD 2, the two
groups were equivalent. We did not track time to first
flatus or first bowel movements as we feel these measures
are less reliable. Diet advancement was typically a function
of patient appetite and this has been shown to be good
indicators for bowel function [54].
Return of bladder function was measured in terms of
duration of urinary catheterization, which was signifi-
cantly less in the ERAS group. We did attempt to deter-
mine catheter re-insertion rates but reporting and
tracking was poor as a wide variety of criteria were used
to reinsert catheters or to use a straight catheter for one
time assistance with voiding based on individual pro-
vider preference.
It remains to be seen if ERAS programs improve
patient satisfaction while accelerating recovery [55]. In
the future, we intend to advance the perioperative surgi-
cal home model by investigating patient satisfaction and
financial impacts of ERAS programs compared to trad-
itional care. We believe these studies are important to
help guide healthcare in the direction of better quality
and better value.
Limitations
Retrospectively analyzing data from a prospective program
especially one directed towards continuous quality
improvement comes with its own challenges. Although
the two groups were fairly well balanced, there were some
differences. Of note, the pre-ERAS and ERAS groups had
significantly different rates of smoking and hypertension.
Our only explanation for the statistically significant differ-
ences in rates of smoking and hypertension between the
two groups is that the ERAS group was temporally after
the pre-ERAS group and the difference may be a reflec-
tion of the medical center’s continued push to decrease
tobacco utilization amongst patient and in the commu-
nity. Such differences are to be expected in a retrospective
analysis without randomization. As stated above, no pa-
tients were excluded from either cohort to reach complete
balance of these associated medical conditions.
Given the evidence-based nature of the ERAS pro-
gram, it would have been unethical to withhold such
care in the control arm of a randomized clinical trial.
We were also resource-constrained in finding matching
controls in historical data, since we switched to a new
electronic medical system in June 2012 from when data
was systematically available. Due to the wide area ser-
viced by a tertiary care center, we are unlikely to have
captured all readmissions if patient were readmitted to
local hospitals outside of our system. This rate should
not be different for our two study groups; therefore, we
are confident in our finding of reduced readmission
rates. Specific complication rates were not tracked. Re-
duced LOS and reduced readmission rates served as
surrogate markers of reduced complication rates since
any significant complications would have adversely affect
one or both of those outcome measures. The 30-day
mortality rate for both groups was zero and the re-
operation rate was not different. Although we have
shown a significant improvement in various outcomes,
we were unable to determine the degree of impact of the
various components of the program and separate the
critical components from the ones that were adjuncts.
This is an area of future focus.
Conclusion
Use of a multidisciplinary evidence-based program is as-
sociated with improved outcomes and decreased recov-
ery time in the perioperative care of patients undergoing
abdominal colorectal surgery. While numerous models
for such programs are available for review, a successful
program requires input from several key disciplines and
adaptation to local factors. Adoption of such programs
in the care of surgical patients should be encouraged.
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